英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Encoded查看　Encoded　在百度字典中的解释百度英翻中〔查看〕
Encoded查看　Encoded　在Google字典中的解释Google英翻中〔查看〕
Encoded查看　Encoded　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Encoded Therapeutics – Translating Next-Generation Science into . . .
    Translating Next-Generation Science Into Transformative Gene Therapies Learn About Our Programs
  • News – Encoded Therapeutics
    News Events Press Releases March 25, 2026 Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome January 12, 2026 Encoded Therapeutics Announces U S FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome January
  • Programs – Encoded Therapeutics
    Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on pediatric central nervous system (CNS) disorders
  • About – Encoded Therapeutics
    Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients Our diversity – whether gender, ethnicity, sexual orientation, religion, age or disability – is one of our biggest strengths as an organization
  • Clinical Studies – Encoded Therapeutics
    Data from observational studies and clinical trials, which depend on volunteer participants, form the foundation of regulatory authorities’ decisions to approve new therapies for broader use
  • Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and . . .
    Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J P Morgan Healthcare Conference – Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome – – Internal GMP manufacturing capable of supporting pivotal trial and commercialization of
  • ETX101 for Dravet Syndrome – Encoded Therapeutics
    Encoded is developing ETX101, a potential one-time, disease-modifying gene regulation therapy for SCN1A+ Dravet syndrome ETX101, Encoded’s lead program, is specifically designed to address the underlying cause of Dravet syndrome, the most common developmental and epileptic encephalopathy ETX101 is a cell-selective gene therapy in development to potentially address the full range of seizure
  • Encoded Therapeutics Strengthens Clinical Leadership Team with . . .
    Encoded Therapeutics Strengthens Clinical Leadership Team with Appointment of Professor Joseph Sullivan, M D , as Vice President of Clinical Development – Globally recognized pediatric epileptologist and clinical researcher brings deep expertise in Dravet syndrome and genetic medicine – SOUTH SAN FRANCISCO, Calif – December 16, 2025 – Encoded Therapeutics Inc (“Encoded”), a
  • Careers – Encoded Therapeutics
    Encoded team members are creative, passionate and collaborative We invite you to join us in our mission to develop transformative therapies by fostering a culture of relentless patient focus, creativity and scientific exploration





中文字典-英文字典  2005-2009